2021
|
Invention
|
Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infections.
The... |
|
Invention
|
Methods and compositions for the inhibition of hepatitis b and hepatitis d virus infections. The ... |
2015
|
Invention
|
Methods for the treatment of hepatitis b and hepatitis d infections. It is disclosed a method for... |
|
Invention
|
Methods for the treatment of hepatitis b and hepatitis d virus infections. It is disclosed a meth... |
2013
|
Invention
|
Oligonucleotide chelate complexes. The present disclosure describes the broadly active chelation ... |
|
Invention
|
Oligonucleotide chelate complex methods. It is described pharmaceutical compositions and methods ... |
|
Invention
|
Oligonucleotide chelate complex-polypeptide compositions and methods. It is disclosed a pharmaceu... |
|
Invention
|
Oligonucleotide chelate complex—polypeptide compositions and methods. It is disclosed a pharmaceu... |
2011
|
Invention
|
Methods for inhibition of apolipoprotein h. The present disclosure relates to methods for ... |
2009
|
Invention
|
Antiviral oligonucleotides targeting rsv.
Random sequence oligonucleotides that have antiviral a... |
|
Invention
|
Antiviral oligonucleotides targeting viral families.
Random sequence oligonucleotides that have ... |
2008
|
Invention
|
Antiviral oligonucleotides targeting hbv. Random sequence oligonucleotides that have antiviral ac... |
|
Invention
|
Antiviral oligonucleotides targeting viral families. Random sequence oligonucleotides that have a... |
|
Invention
|
Antiviral oligonucleotides. Random sequence oligonucleotides that have antiviral activity are des... |
2006
|
Invention
|
Anti-inflammatory molecules and their uses. The invention relates to oligonucleotides acting pred... |
|
Invention
|
Therapeutic molecules and their uses. The present invention relates with the identification... |
|
Invention
|
Therapeutic molecules and their uses. The present invention relates with the identification and u... |
|
Invention
|
Antimicrobial molecules and their uses. The present invention relates with the identification and... |
|
Invention
|
Anti-ocular angiogenesis molecules and their uses. The invention relates to oligonucleotides inhi... |
|
Invention
|
Oligonucleotides inhibiting cell proliferation. The present invention is concerned with the ident... |
|
Invention
|
Anti amyloid-related disease molecules and their uses. Oligonucleotides formulation comprising ol... |
|
Invention
|
Sulfur oligonucleotides having antiviral activities. Sulfur oligonucleotides having antiviral act... |
2005
|
Invention
|
Antiviral oligonucleotides.
Random sequence oligonucleotides that have antiviral activity are de... |
|
Invention
|
Antiviral oligonucleotides. Random sequence oligonucleotides that have antiviral activity a... |
|
Invention
|
Oligonucleotides targeting prion diseases and uses. Oligonucleotide compounds active against prio... |
|
Invention
|
Method for inhibiting cellular proliferation. The present invention relates to a method and compo... |
2004
|
Invention
|
Oligonucleotides targeting prion diseases.
Randomer phosphorothioate oligonucleotide composition... |
|
Invention
|
Oligonucleotides targeting prion diseases. Randomer phosphorothioate oligonucleotide compos... |
|
Invention
|
Oligonucleotides targeting prion diseases. Randomer phosphorothioate oligonucleotide compositions... |
2003
|
Invention
|
Antiviral oligonucleotides targeting rsv. Random sequence oligonucleotides that have antiviral ac... |
|
Invention
|
Antiviral oligonucleotides targeting hiv. Random sequence oligonucleotides that have antiviral ac... |